Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Xometry, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
80.2
141
218
381
463
546
687
Cost of revenue
65.5
108
161
235
285
330
418
Gross profit
14.7
33.3
57.1
146
178
216
269
Research and development
10.6
12.2
17.8
31
34.5
39.3
46.8
Selling and marketing
14.6
22.6
39.4
84.4
93.7
108
123
General and administrative
8.02
12
34.9
58.2
70.9
65
72.3
Operating expenses
45.3
62.5
116
223
252
272
314
Operating income
-30.5
-29.2
-58.7
-77.1
-73.6
-56.1
-45.5
Interest expense
0.24
1.09
0.85
4.42
4.78
4.75
4.91
Interest income
0.98
4.12
11.6
10.8
8.57
Other non-operating income
-0.45
-1.87
-2.7
-1.92
5.76
5.73
-15.6
Pre-tax income
-31.1
-61.4
-79
-67.8
-50.4
-61.2
Income tax
0.04
-0.35
-0.02
0.59
Net income to minority interests
-0
0.02
0.01
-0
-0.01
Net income
-31
-31.1
-61.4
-79.1
-67.5
-50.4
-61.7
EBITDA
-28.7
-26.1
-55.1
-69.3
-62.8
-43.1
-26.8
EPS, basic
-4.88
-5.32
-2.33
-1.68
-1.41
-1.03
EPS, diluted
-4.88
-5.32
-2.33
-1.68
-1.41
-1.03
Shares, basic (weighted)
6.35
7.49
26.3
47.2
47.9
49.1
Shares, diluted (weighted)
6.35
7.49
26.3
47.2
47.9
49.1
Balance sheet
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
59.9
86.3
65.7
53.4
22.2
15
Short-term investments
0
30.5
254
215
218
204
Receivables
14.6
32.4
49.3
70.1
74
97.4
Inventory
2.29
2.03
1.57
2.89
3.92
3.92
Other current assets
0.91
5.58
9.37
8.9
4.87
6.95
Total current assets
77.7
163
387
356
328
335
Property, plant and equipment
6.11
10.3
19.1
35.6
44.8
60.6
Lease right-of-use assets
1.92
27.5
25.9
12.3
8.46
11.1
Goodwill
2.19
0.83
255
258
263
263
264
Intangible assets
1.65
41.7
39.4
35.8
32.1
28.6
Other non-current assets
0.79
0.77
0.41
0.47
0.41
0.88
Total assets
89
503
734
707
680
704
Accounts payable
5.64
12.7
12.4
24.7
Accrued liabilities
13.6
30.9
33.4
41.8
Deferred revenue
1.82
2.36
7.86
8.73
7.36
7.95
10.3
Short-term debt
15.8
Total current liabilities
38.4
57
64
83.2
74.8
88.9
Lease liabilities
1.12
16.9
16.9
11
5.07
9.84
Other non-current liabilities
1.68
1.01
0.78
0.82
0.55
Total liabilities
39.5
77.1
362
377
365
427
Paid-in capital
0.5
598
623
648
685
711
Retained earnings
-112
-173
-252
-320
-370
-432
Treasury stock
0
-8.08
Other comprehensive income
0.21
0.15
0.03
0.86
-0.33
4.77
Shareholders' equity
-73.1
-111
424
371
329
314
276
Minority interests
1.03
1.09
1.12
1.14
1.14
Total equity
-73.1
-111
425
372
330
316
277
Total liabilities and equity
89
503
734
707
680
704
Shares outstanding
7.76
0
Cash flow statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-31
-31.1
-61.4
-79
-67.5
-50.4
-61.7
Depreciation and amortization
1.85
3.12
3.6
7.82
10.7
13
18.8
Stock-based compensation
0.54
1.01
7.4
19.2
22.1
29.3
36.4
Deferred income tax
0
0
-0.18
-0.65
-0.15
-0.05
-0.08
Change in receivables
-5.51
-2.13
-11.1
-17
-20.6
-5.75
-21.8
Change in inventory
-0.56
-0.96
0.29
0.35
-1.55
-1.28
0.14
Change in payables
2.81
-2.35
5.22
-0.22
6.74
Cash from operations
-27.1
-22
-68.6
-62.6
-29.9
-15.4
6.09
Capital expenditures
-2.69
-4.19
-6.26
-13.7
-18.5
-18.1
-30.2
Acquisitions
-1.43
-175
-3.35
0
0
Purchases of investments
-28.9
-17.7
-267
-284
-11.6
-18.8
-8.54
Sales and maturities of investments
235
58.9
50
16.5
22
Cash from investing
-2.35
6.67
-213
-239
16.8
-20.2
-16.6
Stock issued
0.45
0.52
2.29
3.72
1.91
5.1
3.09
Share buybacks
0
0
-8.08
Cash from financing
54.7
35.3
308
281
1.07
4.64
2.89
Net change in cash
25.2
19.8
26.4
-20.6
-12.2
-31.2
-7.24
Free cash flow
-29.8
-26.2
-74.8
-76.2
-48.4
-33.5
-24.1
Interest paid
1.11
1.27
0.91
1.41
2.88
2.88
3.55
Income taxes paid
1.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $100.57 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
38.7%
Gross profit / revenue.
Operating margin
-3.8%
Operating income / revenue.
EBITDA margin
-1.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.7%
Pre-tax income / revenue.
Net margin
-3.8%
Net income / revenue.
Operating cash flow margin
3.4%
Cash from operations / revenue.
Return on equity (ROE)
-5.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.9%
Net income / average total assets.
Return on invested capital (ROIC)
-4.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
6.1%
Research and development expense / revenue.
Stock-based pay / revenue
5.1%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
2.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
25.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
21.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
37.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
24.6%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
22.6%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
51.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-12.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-9.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
3.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-1.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
51.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.21x
Current assets / current liabilities.
Quick ratio
3.09x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.47x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
7.14x
Market cap / revenue.
P/B
9.69x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
18.9x
Market cap / tangible book value, when positive.
P/OCF
208x
Market cap / cash from operations, when positive.
EV/Sales
6.50x
Enterprise value / revenue.
Earnings yield
-0.5%
Net income / market cap (the inverse of P/E).
What was Xometry, Inc.'s revenue in fiscal 2025?
Xometry, Inc. reported revenue of $686.6M for fiscal 2025, 25.9% higher than the year before.
Was Xometry, Inc. profitable in fiscal 2025?
No. It reported a net loss of $61.7M.
How much free cash flow did Xometry, Inc. generate in fiscal 2025?
Cash from operations of $6.1M minus capital expenditures of $30.2M left free cash flow of -$24.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.